trial
as of 2026-07-01Psychosis-Associated Neuroinflammation in Schizophrenia
NCTId NCT02009826
at a glance
Phase — · Completed
Enrollment 106 (actual)
Sponsored by Universiteit Antwerpen
Primary completion 2017-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
106 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2013-11
Primary completion
2017-02
Eligibility
ALL · 18 Years · 40 Years
Interventions & indications
Sponsors
Universiteit AntwerpenLead Sponsor
Investigators
1
Bernard Sabbe, MD PhDPrincipal Investigator
Sites
3 total
Boechout, BelgiumDuffel, BelgiumMortsel, Belgium
Facts & assertions
4 sourced
Enrollment
106
Phase
NA
Primary Completion Date
2017-02
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
investigator
person